Reactogenicity to COVID-19 vaccination in the United States of America
Authors:
- Adekunle SanyaoluAdekunle Sanyaolu
- Aleksandra MarinkovicAMAleksandra Marinkovic
- Stephanie PrakashSPStephanie Prakash
- Priyank DesaiPDPriyank Desai
- Nafees HaiderNHNafees Haider
- Abu Fahad AbbasiAAAbu Fahad Abbasi
- Nasima MehrabanNMNasima Mehraban
- Isha JainIJIsha Jain
- Amarachi EkehAEAmarachi Ekeh
- Omar ShazleyOmar Shazley
- Chuku OkorieCOChuku Okorie
- Verner N. OrishVOVerner N. Orish
Open Access
- 1 January 2022
- journal article
- research article
- Published by Korean Vaccine Society in Clinical and Experimental Vaccine Research
- Vol. 11 (1) , 104-115
Abstract
Sanyaolu A, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):104-115. https://doi.org/10.7774/cevr.2022.11.1.104Keywords
This publication has 22 references indexed in Scilit:
- Reactogenicity Following Receipt of mRNA-Based COVID-19 VaccinesJAMA, 2021
- Acute Allergic Reactions to mRNA COVID-19 VaccinesJAMA, 2021
- mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested ApproachThe Journal of Allergy and Clinical Immunology: In Practice, 2021
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineNew England Journal of Medicine, 2021
- What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2The Lancet Infectious Diseases, 2021
- Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine boosterMedical Hypotheses, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020
- Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19New England Journal of Medicine, 2020
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infectionsNature Medicine, 2020
- A statistical analysis of vaccine-adverse event dataBMC Medical Informatics and Decision Making, 2019